2026-01-26 - Analysis Report
**Johnson & Johnson (JNJ) Stock Analysis Report**

### Company Overview
Johnson & Johnson is a multinational healthcare company that develops and markets pharmaceutical, medical device, and consumer packaged goods.

### Performance Comparison

**Return Rate Analysis**

* Cumulative return of review stock (JNJ): 77.12%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence (current): -48.70
* Relative divergence: 40.60%

### Historical Performance

| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Capital (B)** |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 9.0% | 16.9% | -3.0% | 0.7 | 310.9 |
| 2017-2019 | 21.0% | 16.9% | -4.0% | 0.7 | 351.4 |
| 2018-2020 | 13.0% | 25.9% | -12.0% | 0.7 | 379.2 |
| 2019-2021 | 26.0% | 25.9% | -39.0% | 0.6 | 412.2 |
| 2020-2022 | 15.0% | 25.9% | 8.0% | 0.5 | 425.6 |
| 2021-2023 | -11.0% | 14.1% | -31.0% | 0.3 | 377.6 |
| 2022-2024 | -23.0% | 14.1% | -53.0% | 0.2 | 348.4 |
| 2023-2025 | 37.0% | 14.1% | -38.0% | 0.1 | 498.6 |

### Recent Stock Price Fluctuations

* Close: $220.14
* Last-market: $220.14
* Previous Close: $218.49
* Change: $0.76
* 5-day SMA: $218.70
* 20-day SMA: $211.30
* 60-day SMA: $203.76

### Technical Analysis

* Market Risk Indicator (MRI): 0.70 (medium risk)
* RSI: 72.69
* PPO: 0.38
* Hybrid Signal: Buy
* Recent (20 days) relative divergence change: +1.40 (improving)
* 7-day Rank change: 0 (flat)
* 7-day Dynamic Expected Return change: 0.00 (flat)
* Expected Return (%): -64.10% (expected excess return compared to S&P 500)

### Recent News & Events

* [2026-01-22] How Two Rivals Undercut J&J's Beat And Big Guidance - Investor's Business Daily
* [2026-01-21] Johnson & Johnson forecasts 2026 profit above Wall Street estimates - CNBC
* [2026-01-21] J&J stock drops after Q4 2025 results (JNJ:NYSE) - Seeking Alpha
* [2026-01-21] J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal - Reuters
* [2026-01-19] Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? - Yahoo Finance
* [2025-12-30] More Upside For JNJ Stock In 2026? - Forbes

### Analyst Opinions

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.16 (~Buy)
  - Opinions: 24
  - Target Price (avg/high/low): 224.09 / 265.00 / 155.00

### Recent Earnings Analysis

| **Date** | **EPS** | **Revenue** |
| --- | --- | --- |
| 2025-10-22 | 2.14 | $23.99B |
| 2025-07-24 | 2.3 | $23.74B |
| 2025-04-23 | 4.57 | $21.89B |
| 2024-10-23 | 1.12 | $22.47B |
| 2025-10-22 | 1.12 | $22.47B |

### Financial Information

**Revenue and Profitability**

| **Quarter** | **Revenue** | **Profit Margin** |
| --- | --- | --- |
| 2025-09-30 | $23.99B | 69.56% |
| 2025-06-30 | $23.74B | 67.87% |
| 2025-03-31 | $21.89B | 66.40% |
| 2024-12-31 | $22.52B | 68.35% |

**Capital and Profitability**

| **Quarter** | **Equity** | **ROE** |
| --- | --- | --- |
| 2025-09-30 | $79.28B | 6.50% |
| 2025-06-30 | $78.47B | 7.06% |
| 2025-03-31 | $78.11B | 14.08% |
| 2024-12-31 | $71.49B | 4.80% |

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.